Daewoong Co., Ltd. (003090.KS)
KRW 20450.0
(0.74%)
KRW 20450.0
(0.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 248.36 Billion KRW | 10.66% |
| 2022 | 211.37 Billion KRW | 29.06% |
| 2021 | 171.18 Billion KRW | -13.28% |
| 2020 | 203.81 Billion KRW | 31.0% |
| 2019 | 139.36 Billion KRW | 0.9% |
| 2018 | 148.27 Billion KRW | 3.52% |
| 2017 | 131.62 Billion KRW | 44.1% |
| 2016 | 99.76 Billion KRW | -16.09% |
| 2015 | 116.42 Billion KRW | 8.26% |
| 2014 | 106.42 Billion KRW | -16.16% |
| 2013 | 126.25 Billion KRW | 173.21% |
| 2012 | 111.34 Billion KRW | 27.3% |
| 2011 | 61.31 Billion KRW | -64.62% |
| 2010 | 109.64 Billion KRW | -21.34% |
| 2009 | 113.73 Billion KRW | 99.58% |
| 2008 | 89.87 Billion KRW | -32.99% |
| 2007 | 108.08 Billion KRW | 12.72% |
| 2006 | 91.54 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 82.88 Billion KRW | 38.29% |
| 2024 Q1 | 62.27 Billion KRW | 13.95% |
| 2023 Q2 | 469.42 Billion KRW | 667.72% |
| 2023 Q4 | 27.61 Billion KRW | -94.02% |
| 2023 FY | - KRW | 10.66% |
| 2023 Q3 | 461.51 Billion KRW | -1.68% |
| 2023 Q1 | 61.14 Billion KRW | 257.21% |
| 2022 Q2 | 70.55 Billion KRW | 17.87% |
| 2022 FY | - KRW | 29.06% |
| 2022 Q4 | 17.11 Billion KRW | -75.56% |
| 2022 Q3 | 70.04 Billion KRW | -0.72% |
| 2022 Q1 | 59.85 Billion KRW | 0.13% |
| 2021 Q3 | 61.82 Billion KRW | 10.54% |
| 2021 FY | - KRW | -13.28% |
| 2021 Q1 | -1.78 Billion KRW | -101.81% |
| 2021 Q2 | 55.93 Billion KRW | 3231.88% |
| 2021 Q4 | 59.78 Billion KRW | -3.31% |
| 2020 FY | - KRW | 31.0% |
| 2020 Q4 | 98.65 Billion KRW | 148.16% |
| 2020 Q1 | 36.91 Billion KRW | 84.4% |
| 2020 Q2 | 32.14 Billion KRW | -12.92% |
| 2020 Q3 | 39.75 Billion KRW | 23.68% |
| 2019 FY | - KRW | 0.9% |
| 2019 Q4 | 20.01 Billion KRW | -40.7% |
| 2019 Q1 | 38.08 Billion KRW | 11.99% |
| 2019 Q3 | 33.75 Billion KRW | -36.59% |
| 2019 Q2 | 53.23 Billion KRW | 39.79% |
| 2018 FY | - KRW | 3.52% |
| 2018 Q1 | 37.29 Billion KRW | -2.1% |
| 2018 Q2 | 41.64 Billion KRW | 11.66% |
| 2018 Q4 | 34 Billion KRW | -14.83% |
| 2018 Q3 | 39.92 Billion KRW | -4.12% |
| 2017 Q4 | 38.09 Billion KRW | -6.78% |
| 2017 Q2 | 36.9 Billion KRW | 32.0% |
| 2017 FY | - KRW | 44.1% |
| 2017 Q3 | 40.86 Billion KRW | 10.72% |
| 2017 Q1 | 27.96 Billion KRW | -17.49% |
| 2016 FY | - KRW | -16.09% |
| 2016 Q2 | 26.09 Billion KRW | 82.87% |
| 2016 Q4 | 33.88 Billion KRW | 23.09% |
| 2016 Q1 | 14.26 Billion KRW | -36.78% |
| 2016 Q3 | 27.53 Billion KRW | 5.5% |
| 2015 Q4 | 22.57 Billion KRW | -28.59% |
| 2015 Q2 | 35.16 Billion KRW | 5.1% |
| 2015 FY | - KRW | 8.26% |
| 2015 Q1 | 33.45 Billion KRW | 51.26% |
| 2015 Q3 | 31.6 Billion KRW | -10.11% |
| 2014 Q4 | 22.11 Billion KRW | -16.82% |
| 2014 FY | - KRW | -16.16% |
| 2014 Q3 | 26.58 Billion KRW | -16.06% |
| 2014 Q2 | 31.67 Billion KRW | 0.21% |
| 2014 Q1 | 31.6 Billion KRW | 25.3% |
| 2013 FY | - KRW | 173.21% |
| 2013 Q2 | 39.44 Billion KRW | 33.15% |
| 2013 Q3 | 39.05 Billion KRW | -0.98% |
| 2013 Q4 | 25.22 Billion KRW | -35.41% |
| 2013 Q1 | 29.62 Billion KRW | 257.48% |
| 2012 Q1 | 11.7 Billion KRW | 0.0% |
| 2012 FY | - KRW | 27.3% |
| 2012 Q4 | -18.81 Billion KRW | -161.28% |
| 2012 Q3 | 30.69 Billion KRW | 122.72% |
| 2012 Q2 | 13.78 Billion KRW | 17.73% |
| 2011 Q1 | 2.9 Billion KRW | 0.0% |
| 2011 FY | - KRW | -64.62% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 Q3 | 2.47 Billion KRW | -2.92% |
| 2011 Q2 | 2.54 Billion KRW | -12.13% |
| 2010 Q1 | - KRW | 100.0% |
| 2010 FY | - KRW | -21.34% |
| 2010 Q2 | -350.96 Million KRW | 0.0% |
| 2010 Q3 | -8.83 Billion KRW | -2417.68% |
| 2009 Q3 | -6.19 Billion KRW | -18.61% |
| 2009 FY | - KRW | 99.58% |
| 2009 Q1 | - KRW | 100.0% |
| 2009 Q2 | -5.22 Billion KRW | 0.0% |
| 2009 Q4 | -9.8 Billion KRW | -58.14% |
| 2008 Q4 | -2.77 Billion KRW | 13.86% |
| 2008 Q1 | - KRW | 100.0% |
| 2008 Q3 | -3.22 Billion KRW | 52.51% |
| 2008 Q2 | -6.79 Billion KRW | 0.0% |
| 2008 FY | - KRW | -32.99% |
| 2007 Q2 | -116.53 Million KRW | 0.0% |
| 2007 Q4 | -7.1 Billion KRW | -61.8% |
| 2007 FY | - KRW | 12.72% |
| 2007 Q3 | -4.39 Billion KRW | -3669.41% |
| 2006 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PharmGen Science, Inc. | 13.37 Billion KRW | -1757.132% |
| Wooridul Huebrain Limited | -20.87 Billion KRW | 1289.726% |